European Journal of Dermatology
MENUGreater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study Volume 28, numéro 3, May-June 2018
Citer cet article
Citation de l'article, à la forme « Vancouver » :
Christopher EM Griffiths, Linda Stein Gold, Frédéric Cambazard, Robert E Kalb, David Lowson, Anders Møller, Carle Paul. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. European Journal of Dermatology. 2018;28(3):356-363. doi:10.1684/ejd.2018.3302